LYNCH DANIEL sold 57.2% of their position (175K shares) of SPRINGWORKS THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.53M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/12/2025ACC: 0001104659-25-012364
Director
Since Sep 2019
-175K
Net shares
Net seller
$9.53M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
175K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−69.77K
Price / share
$53.23
Trade value
$3.71M
% of position
22.8%
2/10/2025
305.94K→236.18K
Common Stock
Direct
Shares
−39.63K
Price / share
$54.88
Trade value
$2.18M
% of position
16.8%
2/10/2025
236.18K→196.54K
Common Stock
Direct
Shares
−65.60K
Price / share
$55.51
Trade value
$3.64M
% of position
33.4%
2/10/2025
196.54K→130.94K
Total
Net shares
−175K
Net value
-$9.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2025 | S · Sale | −69.77K | $53.23 | $3.71M | 22.8% | 305.94K | 236.18K |
| Common Stock Direct | 2/10/2025 | S · Sale | −39.63K | $54.88 | $2.18M | 16.8% | 236.18K | 196.54K |
| Common Stock Direct | 2/10/2025 | S · Sale | −65.60K | $55.51 | $3.64M | 33.4% | 196.54K | 130.94K |
| Total | −175K | -$9.53M | ||||||
Derivative Transactions0
No derivative transactions reported